Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Zoledronic acid.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Zoledronic acid.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Zoledronic acid.
Advertisement
Aclarubicin
Aclarubicin may increase the hypocalcemic activities of Zoledronic acid.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Zoledronic acid.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Zoledronic acid.
Advertisement
Aluminum
The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminium.
Aluminum Hydroxide
The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminum hydroxide.
Advertisement
Aluminum Magnesium Silicate
The serum concentration of Zoledronic acid can be decreased when it is combined with Almasilate.
Amikacin
Amikacin may increase the hypocalcemic activities of Zoledronic acid.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Zoledronic acid.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Zoledronic acid.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Zoledronic acid.
Arbekacin
Arbekacin may increase the hypocalcemic activities of Zoledronic acid.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Zoledronic acid.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Zoledronic acid.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Zoledronic acid.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Zoledronic acid.
Bismuth Subcitrate
The serum concentration of Zoledronic acid can be decreased when it is combined with Bismuth Subcitrate.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Zoledronic acid.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Zoledronic acid.
Calcium Acetate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Acetate.
Calcium Carbonate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Carbonate.
Calcium Chloride
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Chloride Anhydrous
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Citrate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Citrate.
Calcium Glubionate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium glubionate.
Calcium gluceptate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Gluceptate.
Calcium Gluconate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium gluconate.
Calcium Lactate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium lactate.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Zoledronic acid.
Casein Allergenic Extract
The serum concentration of Zoledronic acid can be decreased when it is combined with Casein.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Zoledronic acid.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Zoledronic acid.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Zoledronic acid.
Clofezone
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Zoledronic acid.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Zoledronic acid.
Daunorubicin
Daunorubicin may increase the hypocalcemic activities of Zoledronic acid.
Deferasirox
The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Deferasirox.
Dexlansoprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Dexlansoprazole.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Zoledronic acid.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Zoledronic acid.
Dihydrostreptomycin
Dihydrostreptomycin may increase the hypocalcemic activities of Zoledronic acid.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Zoledronic acid.
Doxorubicin
Doxorubicin may increase the hypocalcemic activities of Zoledronic acid.
Doxorubicin Hydrochloride
Doxorubicin may increase the hypocalcemic activities of Zoledronic acid.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Zoledronic acid.
Epirubicin
Epirubicin may increase the hypocalcemic activities of Zoledronic acid.
Esomeprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Esomeprazole.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Zoledronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Zoledronic acid.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Zoledronic acid.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Zoledronic acid.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Zoledronic acid.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Zoledronic acid.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Zoledronic acid.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Zoledronic acid.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Zoledronic acid.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Zoledronic acid.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Zoledronic acid.
Framycetin
Framycetin may increase the hypocalcemic activities of Zoledronic acid.
Gentamicin
Gentamicin may increase the hypocalcemic activities of Zoledronic acid.
Human calcitonin
Human calcitonin may increase the hypocalcemic activities of Zoledronic acid.
Hydrotalcite
The serum concentration of Zoledronic acid can be decreased when it is combined with Hydrotalcite.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zoledronic acid.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Zoledronic acid.
Idarubicin
Idarubicin may increase the hypocalcemic activities of Zoledronic acid.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Zoledronic acid.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Zoledronic acid.
Iron Sucrose
The serum concentration of Zoledronic acid can be decreased when it is combined with Iron saccharate.
Kanamycin
Kanamycin may increase the hypocalcemic activities of Zoledronic acid.
kanamycin A
Kanamycin may increase the hypocalcemic activities of Zoledronic acid.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Zoledronic acid.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zoledronic acid.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Zoledronic acid.
Lansoprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Lansoprazole.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Zoledronic acid.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Zoledronic acid.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Zoledronic acid.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Zoledronic acid.
Magnesium Hydroxide
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium oxide.
Magnesium Salicylate
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium salicylate.
Magnesium Sulfate
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium sulfate.
Magnesium Trisilicate
The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium Trisilicate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Zoledronic acid.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Zoledronic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Zoledronic acid.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Zoledronic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Zoledronic acid.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Zoledronic acid.
Metrizamide
Metrizamide may increase the hypocalcemic activities of Zoledronic acid.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Zoledronic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Zoledronic acid.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Zoledronic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Zoledronic acid.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Zoledronic acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Zoledronic acid.
Neomycin
Neomycin may increase the hypocalcemic activities of Zoledronic acid.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Zoledronic acid.
Netilmicin
Netilmicin may increase the hypocalcemic activities of Zoledronic acid.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Zoledronic acid.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Zoledronic acid.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Zoledronic acid.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Zoledronic acid.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Zoledronic acid.
Omeprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Zoledronic acid.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Zoledronic acid.
Pantoprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Pantoprazole.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Zoledronic acid.
Paromomycin
Paromomycin may increase the hypocalcemic activities of Zoledronic acid.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Zoledronic acid.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Zoledronic acid.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zoledronic acid.
Pirarubicin
Pirarubicin may increase the hypocalcemic activities of Zoledronic acid.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Zoledronic acid.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Zoledronic acid.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Zoledronic acid.
Plicamycin
Plicamycin may increase the hypocalcemic activities of Zoledronic acid.
Rabeprazole
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Rabeprazole.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Zoledronic acid.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Zoledronic acid.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Zoledronic acid.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Zoledronic acid.
Salmon Calcitonin
Salmon Calcitonin may increase the hypocalcemic activities of Zoledronic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Zoledronic acid.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Zoledronic acid.
Sisomicin
Sisomicin may increase the hypocalcemic activities of Zoledronic acid.
Spectinomycin
Spectinomycin may increase the hypocalcemic activities of Zoledronic acid.
Streptomycin
Streptomycin may increase the hypocalcemic activities of Zoledronic acid.
Streptozocin
Streptozocin may increase the hypocalcemic activities of Zoledronic acid.
Sucroferric Oxyhydroxide
The serum concentration of Zoledronic acid can be decreased when it is combined with Iron saccharate.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zoledronic acid.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Zoledronic acid.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Zoledronic acid.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Zoledronic acid.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Zoledronic acid.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Zoledronic acid.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Zoledronic acid.
Tobramycin
Tobramycin may increase the hypocalcemic activities of Zoledronic acid.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Zoledronic acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Zoledronic acid.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Zoledronic acid.
Tricalcium Phosphate
The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium Phosphate.
Tromethamine
The serum concentration of Zoledronic acid can be decreased when it is combined with Tromethamine.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Zoledronic acid.
Valrubicin
Valrubicin may increase the hypocalcemic activities of Zoledronic acid.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Zoledronic acid.
